Children with HIV in Africa - Pharmacokinetics and Adherence of Simple Antiretroviral Regimens (CHAPAS-2): an open, randomised, controlled, phase I, crossover trial.

Trial Profile

Children with HIV in Africa - Pharmacokinetics and Adherence of Simple Antiretroviral Regimens (CHAPAS-2): an open, randomised, controlled, phase I, crossover trial.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics; Registrational
  • Acronyms CHAPAS2
  • Sponsors Cipla
  • Most Recent Events

    • 03 Jun 2015 According to media release, lopinavir/ritonavir oral pellet formulation has received tentative approval from US FDA.
    • 01 Jun 2014 Results published in the JAIDS.
    • 06 Mar 2013 Results for the syrup versus sprinkle formulation analysis presented at the 20th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top